Anti-inflammatory effects of miR-21 in the macrophage response to peritonitis

Rebecca Elise Barnett1, Daniel J Conklin1, Lindsey Ryan1

  • 1*Hiram C. Polk, Jr., MD, Department of Surgery, School of Medicine, and Division of Cardiovascular Medicine, Department of Medicine, University of Louisville, Louisville, Kentucky, USA; and Robley Rex Veterans Affairs Medical Center, Louisville, Kentucky, USA.

Journal of Leukocyte Biology
|September 19, 2015
PubMed

Insights

MicroRNA-21 is beneficial for survival in lipopolysaccharide-induced peritonitis by modulating macrophage responses. Its suppression increases pro-inflammatory cytokines, highlighting its anti-inflammatory role in sepsis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Peritonitis is a severe inflammatory condition often leading to sepsis.
  • Macrophages play a critical role in the inflammatory response to peritonitis.
  • MicroRNAs are key regulators of gene expression and cellular function.

Purpose of the Study:

  • To investigate the role of microRNA-21 in the macrophage response to peritonitis.
  • To determine the effect of microRNA-21 on survival and inflammatory markers in different models of peritonitis.
  • To elucidate the molecular mechanisms by which microRNA-21 modulates macrophage activity.

Main Methods:

  • Utilized microRNA-21-null mice and bone marrow-derived macrophages.
  • Induced peritonitis using lipopolysaccharide (LPS) or cecal ligation and puncture (CLP).
  • Assayed survival, microRNA-21 levels, target gene/protein expression, and cytokine production. Performed transfections with microRNA-21 mimics and antagomirs.

Main Results:

  • MicroRNA-21-null mice showed decreased survival after LPS-induced peritonitis but not CLP.
  • LPS stimulation increased microRNA-21, TNF-α, IL-6, and decreased PDCD4, Pelino1, and SPRY expression.
  • MicroRNA-21 suppression increased TNF-α and IL-6, decreased IL-10, and increased NF-κB activation in response to LPS.

Conclusions:

  • MicroRNA-21 is crucial for survival in LPS-induced peritonitis, acting as an anti-inflammatory modulator.
  • Its expression influences key inflammatory cytokines and signaling pathways like NF-κB.
  • Understanding microRNA-21's anti-inflammatory effects could lead to novel therapies for peritonitis and sepsis.